Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:3-methylglutaconic aciduria type 3
go back to main search page
Accession:DOID:0110004 term browser browse the term
Definition:A 3-methylglutaconic aciduria that has_material_basis_in mutation in the OPA3 gene. (DO)
Synonyms:exact_synonym: 3-methylglutaconic aciduria, type III;   Costeff optic atrophy syndrome;   Costeff syndrome;   Iraqi Jewish optic atrophy plus;   MGA, type III;   MGA3;   MGCA3;   OPA3, Autosomal Recessive;   Optic Atrophy 3, Autosomal Recessive;   autosomal recessive optic atrophy plus syndrome;   autosomal recessive optic atrophy type 3;   infantile optic atrophy with chorea and spastic paraplegia;   optic atrophy plus syndrome
 primary_id: MESH:C535311
 alt_id: OMIM:258501;   RDO:0000352
 xref: ORDO:67047
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants       view all columns           Sort by:
 
3-methylglutaconic aciduria type 3 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Opa3 OPA3, outer mitochondrial membrane lipid metabolism regulator JBrowse link 1 80,141,630 80,160,145 RGD:7240710
RGD:8554872

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15619
    Nutritional and Metabolic Diseases 4374
      disease of metabolism 4374
        inherited metabolic disorder 1864
          3-methylglutaconic aciduria 12
            3-methylglutaconic aciduria type 3 1
Path 2
Term Annotations click to browse term
  disease 15619
    Developmental Diseases 8737
      Congenital, Hereditary, and Neonatal Diseases and Abnormalities 7519
        genetic disease 7008
          inherited metabolic disorder 1864
            amino acid metabolic disorder 326
              organic acidemia 48
                3-methylglutaconic aciduria 12
                  3-methylglutaconic aciduria type 3 1
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.